Head of Enterprise Architecture at Alfa Laval IT and Process director at Medicon Village. Engineer educated at LTH in Lund with broad experience within Information Sciences, general management and continuous improvement projects at AstraZeneca R&D.
Karin von Wachenfeldt
CEO and cofounder of Truly Translational Sweden AB. Ph. D. In Immunotechnology from Lund University and Marketing Economist (EFL). Broad experience of early stage pharmaceutical development of small molecules and biopharmaceuticals from BioInvent, Pharmacia Upjohn, Active Biotech and AstraZeneca.
CSO and cofounder of Truly Translational Sweden AB. Ph. D. In Medical Sciences from Lund University. Broad experience within In vivo pharmacology and pharmaceutical development of small molecules as well as biologics from Pharmacia Upjohn, Active Biotech, Cartela and AstraZeneca.